Published in Gastroenterology on April 01, 1983
Variability of gastrointestinal transit in healthy women and men. Gut (1996) 1.63
Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa. Gut (1986) 1.63
High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol (2008) 1.22
Gastric motor disturbances in patients with idiopathic rapid gastric emptying. Neurogastroenterol Motil (2011) 1.05
Determinants of delayed gastric emptying in anorexia nervosa and bulimia nervosa. Gut (1988) 1.04
Retrograde gastric pacing reduces food intake and delays gastric emptying in humans: a potential therapy for obesity? Dig Dis Sci (2005) 0.99
GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility. Am J Physiol Endocrinol Metab (2012) 0.95
Effect of high fat-diet and obesity on gastrointestinal motility. Ann Transl Med (2013) 0.92
Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig Dis Sci (1998) 0.92
Prevalence and risk factors for gastroesophageal reflux disease in an impoverished minority population. Obes Res Clin Pract (2010) 0.87
Inhibitory effects and mechanisms of intestinal electrical stimulation on gastric tone, antral contractions, pyloric tone, and gastric emptying in dogs. Am J Physiol Regul Integr Comp Physiol (2008) 0.85
The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. Am J Physiol Regul Integr Comp Physiol (2014) 0.84
The relationship between obesity and functional gastrointestinal disorders: causation, association, or neither? Gastroenterol Hepatol (N Y) (2008) 0.83
Blunted Peripheral and Central Responses to Gastric Mechanical and Electrical Stimulations in Diet-induced Obese Rats. J Neurogastroenterol Motil (2013) 0.83
Dysmotility Symptoms Are Independently Associated With Weight Change: A Population-based Study of Australian Adults. J Neurogastroenterol Motil (2015) 0.83
Visceral response to acute retrograde gastric electrical stimulation in healthy human. World J Gastroenterol (2005) 0.82
Therapeutic potential of gastric electrical stimulation for obesity and its possible mechanisms: a preliminary canine study. Dig Dis Sci (2003) 0.82
Obesity and GERD. Gastroenterol Clin North Am (2013) 0.78
Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial. PLoS One (2016) 0.77
Gastrointestinal morbidity in obesity. Ann N Y Acad Sci (2014) 0.77
Prevalence and determinants of delayed gastric emptying in hospitalised Type 2 diabetic patients. World J Gastroenterol (2008) 0.76
A Review of the Toxicologic Implications of Obesity. J Med Toxicol (2015) 0.76
The role of proximal versus distal stomach resection in the weight loss seen after vertical sleeve gastrectomy. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Relationship of body weight with gastrointestinal motor and sensory function: studies in anorexia nervosa and obesity. BMC Gastroenterol (2017) 0.75
Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets. Front Pharmacol (2016) 0.75
Gastric Emptying, CCK Release, and Satiety in Weight-Stable Obese Subjects. Dig Dis Sci (2005) 0.75
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood (1979) 6.01
Superficial siderosis. Neurology (2006) 2.98
The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis. J Fam Pract (1992) 2.97
National Immunization Survey: the methodology of a vaccination surveillance system. Public Health Rep (2000) 2.04
Overview of the sampling design and statistical methods used in the National Immunization Survey. Am J Prev Med (2001) 2.01
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood (1992) 2.00
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology (1998) 1.98
Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation (1999) 1.79
Relative and seasonal incidences of the sexually transmitted diseases. A two-year statistical review. Br J Vener Dis (1978) 1.65
Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther (2000) 1.58
Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol (2001) 1.51
Recent micturition does not affect the detection of urethral gonorrhoea. Br J Vener Dis (1977) 1.42
Does fluoroscopic guidance for Maloney esophageal dilation impact on the clinical endpoint of therapy: relief of dysphagia and achievement of luminal patency. Gastrointest Endosc (1996) 1.42
Marketing and medicine. Why advertising is not an issue. JAMA (1983) 1.39
A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood (1985) 1.39
Epidemic giardiasis at a resort lodge. Rocky Mt Med J (1976) 1.38
Giardiasis in Colorado: an epidemiologic study. Am J Epidemiol (1977) 1.29
Gastric emptying in patients with chronic renal failure receiving hemodialysis. Arch Intern Med (1984) 1.27
Relationship of hiatal hernia to endoscopically proved reflux esophagitis. Dig Dis Sci (1979) 1.22
Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immun (2001) 1.19
The linkage between immigration and internal migration in large metropolitan areas in the United States. Econ Geogr (1997) 1.19
Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Blood (1987) 1.17
Hepatitis B and the HB-SAg carrier. An outbreak related to sexual contact. JAMA (1975) 1.16
A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience (2001) 1.14
Development of pulmonary fibrosis in mice during infection with Paracoccidioides brasiliensis conidia. J Med Vet Mycol (1992) 1.09
(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology (2001) 1.07
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology (1997) 1.05
Granuloma formation and parasite disintegration in porcine cysticercosis: comparison with human neurocysticercosis. J Comp Pathol (2002) 1.04
Factors associated with screening mammography in low-income women. Am J Prev Med (1996) 1.03
Hepatitis A and B in the family unit. Nonparenteral transmission by asymptomatic children. JAMA (1976) 1.02
An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium. Thromb Haemost (1997) 1.00
Upper-esophageal perforation with a flexible endoscope secondary to cervical osteophytes. Dig Dis Sci (1980) 1.00
Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve (2000) 0.99
Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leuk Res (1987) 0.99
[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells. Neuropharmacology (1999) 0.98
Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood (1990) 0.97
Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma. Cancer Res (1988) 0.96
Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood (1991) 0.95
Use of residual volume as a marker for enteral feeding intolerance: prospective blinded comparison with physical examination and radiographic findings. JPEN J Parenter Enteral Nutr (1992) 0.94
Predictors of outcome after percutaneous treatment for cardiogenic shock. Heart (2005) 0.93
Detection of pyuria and bacteriuria in symptomatic ambulatory women. J Gen Intern Med (1993) 0.93
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte. Blood (1988) 0.91
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. Am J Med (1989) 0.91
Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells. Brain Res Mol Brain Res (1998) 0.90
Fibrotic sequelae in pulmonary paracoccidioidomycosis: histopathological aspects in BALB/c mice infected with viable and non-viable paracoccidioides brasiliensis propagules. Rev Inst Med Trop Sao Paulo (2000) 0.90
The human nervous tissue in proximity to granulomatous lesions induced by Taenia solium metacestodes displays an active response. J Neuroimmunol (2002) 0.90
Transdermal nicotine and gastroesophageal reflux. Am J Gastroenterol (1995) 0.89
Differing patterns of cardiac parasympathetic activity and their evolution in selected patients with a first myocardial infarction. J Am Coll Cardiol (1993) 0.89
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors. Neuropharmacology (1996) 0.89
Brightness acuity test and outdoor visual acuity in cataract patients. J Cataract Refract Surg (1987) 0.88
Finding the medically underserved: a need to revise the federal definition. J Health Care Poor Underserved (1996) 0.87
Antiulcerogenicity of the flavonoid fraction from Erica andevalensis Cabezudo-Rivera. Z Naturforsch C (1997) 0.87
General behavior, toxicity, and cytotoxic activity of elenoside, a lignan from Justicia hyssopifolia. J Nat Prod (2001) 0.87
National, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, 1998. MMWR CDC Surveill Summ (2000) 0.86
Rheumatoid constrictive pericarditis. Br J Rheumatol (1997) 0.86
Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genet Cytogenet (1987) 0.84
Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. J Clin Oncol (1985) 0.84
Three polymorphisms at the D17S29 locus. Nucleic Acids Res (1990) 0.84
Cardioesophageal reflexes: an invasive human study. Dig Dis Sci (2000) 0.84
Letter: Giardial infection from water. Ann Intern Med (1975) 0.84
Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia. Blood (1992) 0.83
Pharmacological effects of elenoside, an arylnaphthalene lignan. Biol Pharm Bull (2001) 0.83
Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Genet Mol Res (2007) 0.83
Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy. J Clin Oncol (1988) 0.83
Simultaneous markers for fluid and solid gastric emptying: new variations on an old theme: concise communication. J Nucl Med (1981) 0.83
Randomized blinded challenge study to assess association between Moraxella bovoculi and Infectious Bovine Keratoconjunctivitis in dairy calves. Vet Microbiol (2013) 0.83
Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated. J Clin Oncol (1996) 0.83
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid. Neuropharmacology (1995) 0.82
Myxedema and upper esophageal dysmotility. Dig Dis Sci (1981) 0.82
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients. Hematol J (2001) 0.82
Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res (1992) 0.82
Philadelphia chromosome-positive adult acute leukemia with monosomy of chromosome number seven: a subgroup with poor response to therapy. Leuk Res (1983) 0.82
The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc Res (1998) 0.81
Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma. Br J Haematol (2004) 0.81
Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia. Blood (1988) 0.81
[3H]LY341495, a highly potent, selective and novel radioligand for labeling Group II metabotropic glutamate receptors. Bioorg Med Chem Lett (1998) 0.81
[Brucellosis: a clinico-epidemiologic study of 139 cases]. Med Clin (Barc) (1983) 0.81
Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia. Blood (1988) 0.81
Evoked cortical activity and speech recognition as a function of the number of simulated cochlear implant channels. Clin Neurophysiol (2009) 0.81
Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosomes 8 and 21. J Clin Oncol (1989) 0.80
Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group. Antimicrob Agents Chemother (1990) 0.80
The Cohen test does not predict outcome in achalasia after pneumatic dilation. Gastrointest Endosc (1993) 0.80
Tuberculous infection in a vascular prosthesis: a case of aortic graft infection resulting from disseminated tuberculosis. Arch Surg (1977) 0.80
Chronic myelogenous leukaemia: haematological remissions with alpha interferon. Br J Haematol (1986) 0.80
Central nervous activity of elenoside. Phytomedicine (2004) 0.80
Diuretic action of an aqueous extract of Lepidium latifolium L. J Ethnopharmacol (1994) 0.79
Reactive pituitary abnormalities in patients with Klinefelter's and Turner's syndromes. Arch Intern Med (1979) 0.79
Osteogenesis imperfecta and coronary artery surgery. A case report. J Cardiovasc Surg (Torino) (1996) 0.79
Antifertility effects of (+)-S-2-amino-6-iodoacetamidohexanoic acid (2-AIHA) in female rats. Contraception (1996) 0.79
Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol (1996) 0.79
Effects of temperature, salinity and body size on routine metabolism of coastal largemouth bass Micropterus salmoides. J Fish Biol (2012) 0.79
External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention. Heart (2007) 0.79